The global softgel capsules market is expected to enjoy a valuation of US$ 1.1 Billion by the end of the year 2022, and further expand at a CAGR of 6.0% to reach a valuation of US$ 1.9 Billion by the year 2032. According to a recent study by Future Market Insights, gelatin softgel capsules are leading the market with a share of about 75.4% in the year 2021, within the global market.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2021 | US$ 1.0 Billion |
Market Value 2022 | US$ 1.1 Billion |
Market Value 2032 | US$ 1.9 Billion |
CAGR 2022 to 2032 | 6.0% |
Market Share of Top 5 Countries | 55.0% |
Key Market Players | Aenova Group GmbH, Fuji Capsule Co., Ltd, Sirio Pharma Company Limited, Catalent, Inc, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Elnova Pharma, Captek Softgel International Inc, Hunan Er-Kang Pharmaceutical Co., Ltd, Soft Gel Technologies Inc., Patheon, United Labs, Curtis Health Caps, Procaps, and Delpharm Evreux |
Softgel capsules have a number of benefits over conventional oral solid dosage forms, and their acceptance as a dosage form is expanding for a number of reasons, including consumer preference. Softgel capsule dosage forms were developed to mask the unpleasant taste and odor of pharmaceuticals. Since soft gelatin capsules are self-lubricating, softgel capsules are simpler to swallow than tablets when taken with water.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for softgel capsules was approximately 35.5% of the overall US$ 3.1 Billion global gelatin capsules market in 2021.
The sale of softgel capsules expanded at a CAGR of 3.9% from 2012 to 2021, owing to the advent of the COVID-19 global pandemic and the associated global burden of disease.
Because of more exact compounding, blending, and dispensing of liquid fill ingredients, it is possible to offer an API with a better degree of accuracy and more consistency between various production lots. Since the entire encapsulation process can be completed inertly to safeguard pharmaceuticals against oxidation and degradation, soft gelatin capsule products often have superior stability.
The gelatin shell's tight seal shields the fill material from contamination by the air as well as the outside environment. In addition to visible light, the shell can be designed to block ultraviolet (UV) light. Additionally, softgel capsule formulation improves operator safety by reducing contamination caused by dust handling.
Softgel capsules (SGCs) appear more appealing and pleasurable to consumers as they can be produced in a variety of forms, sizes, and colors, as well as diverse drug delivery systems such as chewable softgels and meltable softgels.
Softgel capsule producers are increasing their product lines to offer a variety of vegan softgel capsules with improved attributes such as faster disintegration, increased gastric acid resistance, enteric coating, and specially developed capsules for clinical studies in order to maximize their revenue.
Thus, owing to the aforementioned factors, the global softgel capsules market is expected to grow at a CAGR of 6.0% during the forecast period from 2022 to 2032.
Vegetarian softgel capsules are produced by a number of different businesses and include pullulan, starch, and HPMC capsules. This could lead to increased product personalization in the pharmaceutical, cosmetic, and nutraceutical sectors, which could present profitable opportunities for the producers of softgel capsules.
However, some businesses continue to only offer hard and soft gelatin capsules in their product offering. If these companies add softgel capsules, vegetarian capsules, and other capsules made from plant-based gelatin to their product line, they can anticipate significant incremental growth prospects.
Companies are continuing to invest in technologies that provide alternatives to traditional drug delivery systems as the market for softgel products is still in its infancy.
Examples include imprinting the softgel ribbon before encapsulation with any appropriate logos or graphics. The ability to differentiate items through branding, a faster manufacturing process, and a lower risk of counterfeiting because of the label's uniform placement upon each capsule, are all advantages of labeling products before encapsulation. The process also ensures a higher level of quality control as it assists with the identification of fake products.
Thus, the introduction of new technologies to the market, such as the 3D printing of softgel capsules, will be a game-changer, and would further present the global market with lucrative opportunities for expansion.
SGC technology is thought to be relatively expensive to manufacture, which may raise consumer pricing. Many pharmaceutical businesses lack the specialized equipment necessary to fill SGCs, hence they generally rely on contract laboratories/manufacturers for supplies.
SGCs are susceptible to microbial infection and humidity, unlike solid dosage forms. If the medications are not kept in sealed containers or a cool, dry location, this could lead to problems with product stability.
Another issue with the adoption of soft gelatin capsule products is that some people have dietary restrictions that preclude them from eating animal products contained in SGCs. Gelatin is typically derived from pig and cow bones, skins, and other animal parts. Many vegetarians avoid using capsule shells since they are manufactured from animal tissues.
As a result, there are new innovations in animal-free gelatin capsules created from seaweed extract or other sources, although they are often more expensive and difficult to source.
Due to the abundance of providers for softgel capsule goods, the USA now has a market share of approximately 88.4% in North America and is predicted to maintain this growth over the projected period. The expansion of the product portfolios of the country's major players through increased R&D efforts would also help the USA market to flourish.
To increase their market share, manufacturers in the USA softgel capsules market are expanding their line of vegetarian softgel pills with improved qualities such as increased gastric acid resistance, quicker disintegration, enteric coating, and specially designed capsules for clinical trials.
For instance, various businesses produce different kinds of vegetarian supplements, like pullulan, starch, and HPMC capsules. In the nutraceutical, pharmaceutical, and cosmeceutical industries, this may result in greater product personalization and help drive up demand for softgel capsules, claims FMI.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Changsung, founded in 1972, has devoted itself to designing and manufacturing the greatest softgel encapsulation machines, making it the undisputed market leader in Korea and around the world.
All Changsung's machine products are not only certified for international quality standards such as ISO, CE, and UL, but they also comply with the manufacturing standards by cGMP and FDA, satisfying the requirements of a wide variety of customers all over the world.
The USA dominates the North American region with a total market share of about 88.4% in 2021 and is expected to continue to experience the same growth throughout the forecast period, owing to the presence of a large number of suppliers for softgel capsule products. Moreover, the increasing Research and Development activities by the established players in the country to expand their product portfolio will further propel the growth of the global softgel capsules market in the USA
Germany holds approximately 23.3% share of the European market in 2021 and is projected to display growth at a lucrative CAGR of 6.1% during the forecast period. The sales of softgel capsules in the country are supported by the high prevalence of chronic diseases, necessitating the production of nutrition supplements, as well as the presence of a vast geriatric population group susceptible to age-related deficiencies.
China is set to exhibit a CAGR of nearly 7.7% in the global softgel capsules market during the forecast period. With a high presence of contract manufacturing organizations, China holds a dominant share of around 7.9% within the global softgel capsules market. With growing awareness regarding health and personal care, the population group characterized as Gen Z in the country has propelled the demand for supplements and nutraceuticals, which combine traditional and herbal Chinese formulations. This has thus further enhanced the growth of the overall softgel capsules market in China.
The gelatin softgel capsule dosage form has a number of benefits over conventional oral dosage forms, including unit-dose solid dosage form delivery of a liquid matrix engineered to dissolve and enhance the oral bioavailability of a poorly soluble ingredient. Gelatin softgel capsules are expected to present high growth at a CAGR of 4.9% by the end of the forecast period, with a projected market share of about 67.6% in the global market in 2032.
Type-A gelatin (pork skin) holds a revenue share of 43.8% in 2021. Because of their superior strength, resistance to stress, capacity to hold water, higher melting point, faster production time, and low cost, porcine tissues are used to produce a vast majority of softgel capsules, resulting in a bigger market share for this sector.
Vitamin & Dietary Supplements hold a large global market share of about 31.1% in 2021. Softgel capsules improve bioavailability by providing nutrients in solutions or other absorption-enhancing mediums, and growing awareness about the use of health supplements has propelled this segment to be a major growth factor for overall market sales.
Contract manufacturing organizations hold the highest market share of 55.0% during the year 2021. Contract manufacturing is cost-effective and quality-focused practice. Manufacturing pharmaceuticals via a third party saves time, effort, and resources. It lowers labor costs and other expenses that a business must incur to manufacture softgel capsules.
Oral softgels lead the global market in terms of the route of administration, holding a market share of around 40.6% in 2021. Oral softgels are readily digested and disintegrate within a few minutes of entering the stomach. This ensures that the supplement or medication will not travel through the digestive system without being absorbed, increasing pharmacological efficacy and improving treatment outcomes.
There are numerous competitors in the softgel capsules industry, and the whole market is highly fragmented. To meet consumer demand and expand their clientele, these companies are using tactics including acquisitions and mergers partnerships and collaborations, and the introduction of new products.
Instances of key developmental strategies by the industry players in the softgel capsules market are given below:
Similarly, recent developments related to companies manufacturing softgel capsule products have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2012 to 2021 |
Historical Data Available for | 2022 to 2032 |
Market Analysis | US$ Million for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, Israel, and South Africa |
Key Market Segments Covered | Product, Raw Material, Application, End User, Route of Administration, and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
Key players are developing the market by investing in research and development.
The challenge in the softgel capsules market is the high manufacturing cost.
The pharmaceutical industry is the key consumer of the softgel capsules market.
The industry is estimated to reach US$ 1.9 billion by 2032.
The market is expected to record a CAGR of 6.0% through 2032.
1. Executive Summary | Softgel Capsules Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Regulatory Scenario 4.2. Consumption Scenario 4.3. Key Strategies, By Manufacturers 4.4. Product Adoption / Usage Analysis, By Region 4.5. Product USPs / Features (Product Mapping) 4.6. PESTEL analysis 4.7. Porter’s analysis 4.8. Softgel Capsules: Flow Chart 4.9. Tablet in Softgel Capsules 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Life Expectancy Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Advancements In Manufacturing Technology 5.2.3. Introduction Of New Materials 5.2.4. Focus On Developing Non-gelatin-based Capsules 5.2.5. Technical Benefits For Manufacturers And Suppliers 5.2.6. Reduction In Animal Stock Waste 5.2.7. Strategic Collaborations Among Players 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Raw Material 6.1.3. By Application 6.1.4. By End User 6.1.5. By Route of Administration 6.1.6. By Country 6.2. 2021 Market Scenario 7. Global Market Volume (Million Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Volume (Million Units) Analysis, 2012 to 2021 7.2. Current and Future Market Volume (Million Units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Global Average Pricing Analysis Benchmark 8.2. Regional level Pricing Analysis by Product 8.3. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021 9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis By Product, 2012 to 2021 10.3. Current and Future Market Application (US$ Million) and Volume (Million Units) Analysis and Forecast By Product, 2022 to 2032 10.3.1. Gelatin Softgel Capsules 10.3.2. Vegetarian Softgel Capsules 10.4. Market Attractiveness Analysis By Product 11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Raw Material 11.1. Introduction / Key Findings 11.2. Historical Market Application (US$ Million) Analysis, By Raw Material, 2012 to 2021 11.3. Current and Future Market Application (US$ Milion) Analysis and Forecast By Raw Material, 2022 to 2032 11.3.1. Type-A Gelatin (Pork Skin) 11.3.2. Type-B Gelatin (Animal Bones & Skin) 11.3.3. Fish Bone Gelatin 11.3.4. Cellulose Derivatives 11.3.5. Starch Material 11.4. Market Attractiveness Analysis By Raw Material 12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application 12.1. Introduction / Key Findings 12.2. Historical Market Application (US$ Million) Analysis, By Application, 2012 to 2021 12.3. Current and Future Market Application (US$ Million) Analysis Forecast By Application, 2022 to 2032 12.3.1. Antacid & Antiflatulent Preparations 12.3.2. Antianemic Preparations (Hematinic Preparations) 12.3.3. Anti-inflammatory Drugs 12.3.4. Antibiotic & Antibacterial Drugs 12.3.5. Cough & Cold Preparations 12.3.6. Cardiovascular Therapy Drugs 12.3.7. Health Supplements 12.3.8. Vitamin & Dietary Supplements 12.3.9. Other Therapeutic Applications 12.4. Market Attractiveness Analysis By Application 13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User 13.1. Introduction / Key Findings 13.2. Historical Market Application (US$ Million) Analysis, By End User, 2012 to 2021 13.3. Current and Future Market Application (US$ Million) Analysis Forecast By End User, 2022 to 2032 13.3.1. In-house Manufacturing 13.3.1.1. Pharmaceutical Companies 13.3.1.2. Nutraceutical Companies 13.3.1.3. Cosmeceutical Companies 13.3.2. Contract Manufacturing Organizations 13.4. Market Attractiveness Analysis By End User 14. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Route of Administration 14.1. Introduction / Key Findings 14.2. Historical Market Application (US$ Million) Analysis, By Route of Administration, 2012 to 2021 14.3. Current and Future Market Application (US$ Million) Analysis Forecast By Route of Administration, 2022 to 2032 14.3.1. Oral Softgels 14.3.2. Suppositories 14.3.3. Pessaries 14.3.4. Twist off Softgels 14.3.5. Others 14.4. Market Attractiveness Analysis By Route of Administration 15. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region 15.1. Introduction 15.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis By Region, 2012 to 2021 15.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032 15.3.1. North America 15.3.2. Latin America 15.3.3. Europe 15.3.4. East Asia 15.3.5. South Asia 15.3.6. Oceania 15.3.7. Middle East and Africa (MEA) 15.4. Market Attractiveness Analysis By Region 16. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021 16.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032 16.3.1. By Country 16.3.1.1. USA 16.3.1.2. Canada 16.3.2. By Product 16.3.3. By Raw Material 16.3.4. By Application 16.3.5. By End User 16.3.6. By Route of Administration 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Raw Material 16.4.4. By Application 16.4.5. By End User 16.4.6. By Route of Administration 16.5. Market Trends 16.6. Drivers and Restraints - Impact Analysis 16.7. Country-Level Analysis & Forecast 16.7.1. USA Market Analysis 16.7.1.1. .Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By Raw Material 16.7.1.2.3. By Application 16.7.1.2.4. By End User 16.7.1.2.5. By Route of Administration 16.7.2. Canada Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By Raw Material 16.7.2.2.3. By Application 16.7.2.2.4. By End User 16.7.2.2.5. By Route of Administration 17. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021 17.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032 17.3.1. By Country 17.3.1.1. Mexico 17.3.1.2. Brazil 17.3.1.3. Argentina 17.3.1.4. Rest of Latin America 17.3.2. By Product 17.3.3. By Raw Material 17.3.4. By Application 17.3.5. By End User 17.3.6. By Route of Administration 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Raw Material 17.4.4. By Application 17.4.5. By End User 17.4.6. By Route of Administration 17.5. Market Trends 17.6. Drivers and Restraints - Impact Analysis 17.7. Country-Level Analysis & Forecast 17.7.1. Mexico Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Product 17.7.1.2.2. By Raw Material 17.7.1.2.3. By Application 17.7.1.2.4. By End User 17.7.1.2.5. By Route of Administration 17.7.2. Brazil Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Product 17.7.2.2.2. By Raw Material 17.7.2.2.3. By Application 17.7.2.2.4. By End User 17.7.2.2.5. By Route of Administration 17.7.3. Argentina Analysis 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Product 17.7.3.2.2. By Raw Material 17.7.3.2.3. By Application 17.7.3.2.4. By End User 17.7.3.2.5. By Route of Administration 18. Europe Analysis 2012 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021 18.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032 18.3.1. By Country 18.3.1.1. Germany 18.3.1.2. Italy 18.3.1.3. France 18.3.1.4. United Kingdom 18.3.1.5. Spain 18.3.1.6. BENELUX 18.3.1.7. Russia 18.3.1.8. Nordic Countries 18.3.1.9. Rest of Europe 18.3.2. By Product 18.3.3. By Raw Material 18.3.4. By Application 18.3.5. By End User 18.3.6. By Route of Administration 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Raw Material 18.4.4. By Application 18.4.5. By End User 18.4.6. By Route of Administration 18.5. Market Trends 18.6. Drivers and Restraints - Impact Analysis 18.7. Country-Level Analysis & Forecast 18.7.1. Germany Analysis 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Product 18.7.1.2.2. By Raw Material 18.7.1.2.3. By Application 18.7.1.2.4. By End User 18.7.1.2.5. By Route of Administration 18.7.2. Italy Analysis 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. B By Product 18.7.2.2.2. By Raw Material 18.7.2.2.3. By Application 18.7.2.2.4. By End User 18.7.2.2.5. By Route of Administration 18.7.3. France Analysis 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast by Market Taxonomy 18.7.3.2.1. By Product 18.7.3.2.2. By Raw Material 18.7.3.2.3. By Application 18.7.3.2.4. By End User 18.7.3.2.5. By Route of Administration 18.7.4. UK Market Analysis 18.7.4.1. Introduction 18.7.4.2. Market Analysis and Forecast by Market Taxonomy 18.7.4.2.1. By Product 18.7.4.2.2. By Raw Material 18.7.4.2.3. By Application 18.7.4.2.4. By End User 18.7.4.2.5. By Route of Administration 18.7.5. Spain Market Analysis 18.7.5.1. Introduction 18.7.5.2. Market Analysis and Forecast by Market Taxonomy 18.7.5.2.1. By Product 18.7.5.2.2. By Raw Material 18.7.5.2.3. By Application 18.7.5.2.4. By End User 18.7.5.2.5. By Route of Administration 18.7.6. BENELUX Market Analysis 18.7.6.1. Introduction 18.7.6.2. Market Analysis and Forecast by Market Taxonomy 18.7.6.2.1. By Product 18.7.6.2.2. By Raw Material 18.7.6.2.3. By Application 18.7.6.2.4. By End User 18.7.6.2.5. By Route of Administration 18.7.7. Russia Market Analysis 18.7.7.1. Introduction 18.7.7.2. Market Analysis and Forecast by Market Taxonomy 18.7.7.2.1. By Product 18.7.7.2.2. By Raw Material 18.7.7.2.3. By Application 18.7.7.2.4. By End User 18.7.7.2.5. By Route of Administration 18.7.8. Nordic Countries Market Analysis 18.7.8.1. Introduction 18.7.8.2. Market Analysis and Forecast by Market Taxonomy 18.7.8.2.1. By Product 18.7.8.2.2. By Raw Material 18.7.8.2.3. By Application 18.7.8.2.4. By End User 18.7.8.2.5. By Route of Administration 19. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 19.1. Introduction 19.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021 19.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032 19.3.1. By Country 19.3.1.1. China 19.3.1.2. Japan 19.3.1.3. South Korea 19.3.2. By Product 19.3.3. By Raw Material 19.3.4. By Application 19.3.5. By End User 19.3.6. By Route of Administration 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Raw Material 19.4.4. By Application 19.4.5. By End User 19.4.6. By Route of Administration 19.5. Market Trends 19.6. Drivers and Restraints - Impact Analysis 19.7. Country-Level Analysis & Forecast 19.7.1. China Market Analysis 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast by Market Taxonomy 19.7.1.2.1. By Product 19.7.1.2.2. By Raw Material 19.7.1.2.3. By Application 19.7.1.2.4. By End User 19.7.1.2.5. By Route of Administration 19.7.2. Japan Market Analysis 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast by Market Taxonomy 19.7.2.2.1. By Product 19.7.2.2.2. By Raw Material 19.7.2.2.3. By Application 19.7.2.2.4. By End User 19.7.2.2.5. By Route of Administration 19.7.3. South Korea Market Analysis 19.7.3.1. Introduction 19.7.3.2. Market Analysis and Forecast by Market Taxonomy 19.7.3.2.1. By Product 19.7.3.2.2. By Raw Material 19.7.3.2.3. By Application 19.7.3.2.4. By End User 19.7.3.2.5. By Route of Administration 20. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 20.1. Introduction 20.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021 20.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032 20.3.1. By Country 20.3.1.1. India 20.3.1.2. Indonesia 20.3.1.3. Malaysia 20.3.1.4. Thailand 20.3.1.5. Rest of South Asia 20.3.2. By Product 20.3.3. By Raw Material 20.3.4. By Application 20.3.5. By End User 20.3.6. By Route of Administration 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Raw Material 20.4.4. By Application 20.4.5. By End User 20.4.6. By Route of Administration 20.5. Market Trends 20.6. Drivers and Restraints - Impact Analysis 20.7. Country-Level Analysis & Forecast 20.7.1. India Market Analysis 20.7.1.1. Introduction 20.7.1.2. Market Analysis and Forecast by Market Taxonomy 20.7.1.2.1. By Product 20.7.1.2.2. By Raw Material 20.7.1.2.3. By Application 20.7.1.2.4. By End User 20.7.1.2.5. By Route of Administration 20.7.2. Indonesia Market Analysis 20.7.2.1. Introduction 20.7.2.2. Market Analysis and Forecast by Market Taxonomy 20.7.2.2.1. By Product 20.7.2.2.2. By Raw Material 20.7.2.2.3. By Application 20.7.2.2.4. By End User 20.7.2.2.5. By Route of Administration 20.7.3. Malaysia Market Analysis 20.7.3.1. Introduction 20.7.3.2. Market Analysis and Forecast by Market Taxonomy 20.7.3.2.1. By Product 20.7.3.2.2. By Raw Material 20.7.3.2.3. By Application 20.7.3.2.4. By End User 20.7.3.2.5. By Route of Administration 20.7.4. Thailand Market Analysis 20.7.4.1. Introduction 20.7.4.2. Market Analysis and Forecast by Market Taxonomy 20.7.4.2.1. By Product 20.7.4.2.2. By Raw Material 20.7.4.2.3. By Application 20.7.4.2.4. By End User 20.7.4.2.5. By Route of Administration 21. Oceania Market 2012 to 2021 and Forecast 2022 to 2032 21.1. Introduction 21.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021 21.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032 21.3.1. By Country 21.3.1.1. Australia 21.3.1.2. New Zealand 21.3.2. By Product 21.3.3. By Raw Material 21.3.4. By Application 21.3.5. By End User 21.3.6. By Route of Administration 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Product 21.4.3. By Raw Material 21.4.4. By Application 21.4.5. By End User 21.4.6. By Route of Administration 21.5. Key Market Participants - Intensity Mapping 21.6. Drivers and Restraints - Impact Analysis 21.7. Country-Level Analysis & Forecast 21.7.1. Australia Market Analysis 21.7.1.1. Introduction 21.7.1.2. Market Analysis and Forecast by Market Taxonomy 21.7.1.2.1. By Product 21.7.1.2.2. By Raw Material 21.7.1.2.3. By Application 21.7.1.2.4. By End User 21.7.1.2.5. By Route of Administration 21.7.2. New Zealand Market Analysis 21.7.2.1. Introduction 21.7.2.2. Market Analysis and Forecast by Market Taxonomy 21.7.2.2.1. By Product 21.7.2.2.2. By Raw Material 21.7.2.2.3. By Application 21.7.2.2.4. By End User 21.7.2.2.5. By Route of Administration 22. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032 22.1. Introduction 22.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021 22.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032 22.3.1. By Country 22.3.1.1. GCC Countries 22.3.1.2. Turkey 22.3.1.3. Israel 22.3.1.4. South Africa 22.3.1.5. Rest of Middle East and Africa 22.3.2. By Product 22.3.3. By Raw Material 22.3.4. By Application 22.3.5. By End User 22.3.6. By Route of Administration 22.4. Market Attractiveness Analysis 22.4.1. By Country 22.4.2. By Product 22.4.3. By Raw Material 22.4.4. By Application 22.4.5. By End User 22.4.6. By Route of Administration 22.5. Market Trends 22.6. Drivers and Restraints - Impact Analysis 22.7. Country-Level Analysis & Forecast 22.7.1. GCC Countries Market Analysis 22.7.1.1. Introduction 22.7.1.2. Market Analysis and Forecast by Market Taxonomy 22.7.1.2.1. By Product 22.7.1.2.2. By Raw Material 22.7.1.2.3. By Application 22.7.1.2.4. By End User 22.7.1.2.5. By Route of Administration 22.7.2. Turkey Market Analysis 22.7.2.1. Introduction 22.7.2.2. Market Analysis and Forecast by Market Taxonomy 22.7.2.2.1. By Product 22.7.2.2.2. By Raw Material 22.7.2.2.3. By Application 22.7.2.2.4. By End User 22.7.2.2.5. By Route of Administration 22.7.3. Israel Market Analysis 22.7.3.1. Introduction 22.7.3.2. Market Analysis and Forecast by Market Taxonomy 22.7.3.2.1. By Product 22.7.3.2.2. By Raw Material 22.7.3.2.3. By Application 22.7.3.2.4. By End User 22.7.3.2.5. By Route of Administration 22.7.4. South Africa Market Analysis 22.7.4.1. Introduction 22.7.4.2. Market Analysis and Forecast by Market Taxonomy 22.7.4.2.1. By Product 22.7.4.2.2. By Raw Material 22.7.4.2.3. By Application 22.7.4.2.4. By End User 22.7.4.2.5. By Route of Administration 23. Market Structure Analysis 23.1. Market Analysis by Tier of Companies 23.2. Market Share Analysis of Top Players 23.3. Market Presence Analysis 24. Competition Analysis 24.1. Competition Dashboard 24.2. Competition Benchmarking 24.3. Competition Deep Dive 24.3.1. Aenova Group GmbH 24.3.1.1. Overview 24.3.1.2. Product Portfolio 24.3.1.3. Profitability by Market Segments (Product/Channel/Region) 24.3.1.4. Sales Footprint 24.3.1.5. Key Financials 24.3.1.6. SWOT Analysis 24.3.1.7. Strategy Overview 24.3.2. Fuji Capsule Co., Ltd 24.3.2.1. Overview 24.3.2.2. Product Portfolio 24.3.2.3. Profitability by Market Segments (Product/Channel/Region) 24.3.2.4. Sales Footprint 24.3.2.5. Key Financials 24.3.2.6. SWOT Analysis 24.3.2.7. Strategy Overview 24.3.3. Sirio Pharma Company Limited 24.3.3.1. Overview 24.3.3.2. Product Portfolio 24.3.3.3. Profitability by Market Segments (Product/Channel/Region) 24.3.3.4. Sales Footprint 24.3.3.5. Key Financials 24.3.3.6. SWOT Analysis 24.3.3.7. Strategy Overview 24.3.4. Catalent, Inc 24.3.4.1. Overview 24.3.4.2. Product Portfolio 24.3.4.3. Profitability by Market Segments (Product/Channel/Region) 24.3.4.4. Sales Footprint 24.3.4.5. Key Financials 24.3.4.6. SWOT Analysis 24.3.4.7. Strategy Overview 24.3.5. EuroCaps Ltd 24.3.5.1. Overview 24.3.5.2. Product Portfolio 24.3.5.3. Profitability by Market Segments (Product/Channel/Region) 24.3.5.4. Sales Footprint 24.3.5.5. Key Financials 24.3.5.6. SWOT Analysis 24.3.5.7. Strategy Overview 24.3.6. Guangdong Yichao Biological Co., Ltd. 24.3.6.1. Overview 24.3.6.2. Product Portfolio 24.3.6.3. Profitability by Market Segments (Product/Channel/Region) 24.3.6.4. Sales Footprint 24.3.6.5. Key Financials 24.3.6.6. SWOT Analysis 24.3.6.7. Strategy Overview 24.3.7. Elnova Pharma 24.3.7.1. Overview 24.3.7.2. Product Portfolio 24.3.7.3. Profitability by Market Segments (Product/Channel/Region) 24.3.7.4. Sales Footprint 24.3.7.5. Key Financials 24.3.7.6. SWOT Analysis 24.3.7.7. Strategy Overview 24.3.8. Captek Softgel International Inc 24.3.8.1. Overview 24.3.8.2. Product Portfolio 24.3.8.3. Profitability by Market Segments (Product/Channel/Region) 24.3.8.4. Sales Footprint 24.3.8.5. Key Financials 24.3.8.6. SWOT Analysis 24.3.8.7. Strategy Overview 24.3.9. Hunan Er-Kang Pharmaceutical Co., Ltd 24.3.9.1. Overview 24.3.9.2. Product Portfolio 24.3.9.3. Profitability by Market Segments (Product/Channel/Region) 24.3.9.4. Sales Footprint 24.3.9.5. Key Financials 24.3.9.6. SWOT Analysis 24.3.9.7. Strategy Overview 24.3.10. Soft Gel Technologies Inc. 24.3.10.1. Overview 24.3.10.2. Product Portfolio 24.3.10.3. Profitability by Market Segments (Product/Channel/Region) 24.3.10.4. Sales Footprint 24.3.10.5. Key Financials 24.3.10.6. SWOT Analysis 24.3.10.7. Strategy Overview 24.3.11. Patheon 24.3.11.1. Overview 24.3.11.2. Product Portfolio 24.3.11.3. Profitability by Market Segments (Product/Channel/Region) 24.3.11.4. Sales Footprint 24.3.11.5. Key Financials 24.3.11.6. SWOT Analysis 24.3.11.7. Strategy Overview 24.3.12. United Labs 24.3.12.1. Overview 24.3.12.2. Product Portfolio 24.3.12.3. Profitability by Market Segments (Product/Channel/Region) 24.3.12.4. Sales Footprint 24.3.12.5. Key Financials 24.3.12.6. SWOT Analysis 24.3.12.7. Strategy Overview 24.3.13. Curtis Health Caps 24.3.13.1. Overview 24.3.13.2. Product Portfolio 24.3.13.3. Profitability by Market Segments (Product/Channel/Region) 24.3.13.4. Sales Footprint 24.3.13.5. Key Financials 24.3.13.6. SWOT Analysis 24.3.13.7. Strategy Overview 24.3.14. Delpharm Evreux 24.3.14.1. Overview 24.3.14.2. Product Portfolio 24.3.14.3. Profitability by Market Segments (Product/Channel/Region) 24.3.14.4. Sales Footprint 24.3.14.5. Key Financials 24.3.14.6. SWOT Analysis 24.3.14.7. Strategy Overview 24.3.15. Procaps Group 24.3.15.1. Overview 24.3.15.2. Product Portfolio 24.3.15.3. Profitability by Market Segments (Product/Channel/Region) 24.3.15.4. Sales Footprint 24.3.15.5. Key Financials 24.3.15.6. SWOT Analysis 24.3.15.7. Strategy Overview 25. Assumptions and Acronyms Used 26. Research Methodology
Recommendations
Healthcare
July 2017
REP-GB-2782
March 2024
315 pages
Explore Healthcare Insights
View Reports